Owlet Cuts 2026 Revenue Guidance Amid Strategic Pivot to Pediatric Health Platform
Event summary
- Owlet reported Q1 2026 revenue of $22.5M, up 6.4% YoY, but net loss of $3.3M vs. $3.0M net income in Q1 2025.
- Subscription revenue hit a record $2.7M, with over 115,000 paying subscribers for Owlet360.
- CEO Kurt Workman reassumed leadership role, emphasizing focus on high-margin revenue and operational efficiency.
- 2026 revenue guidance lowered to $118M–$122M (12–15% growth) from prior $126M–$130M.
- Adjusted EBITDA guidance raised to $7M–$9M, representing 250–350% growth over 2025.
The big picture
Owlet’s strategic shift toward a comprehensive pediatric health platform reflects broader industry trends of digital health integration and value-based care. The company’s focus on high-margin subscription revenue and operational efficiency aligns with investor demands for profitability in the consumer health sector. However, the lowered revenue guidance signals potential execution risks as Owlet navigates this transition.
What we're watching
- Subscription Scaling
- Whether Owlet can sustain rapid growth in its Owlet360 subscription service amid heightened competition in pediatric health tech.
- Operational Efficiency
- The pace at which Owlet can reduce operating expenses while investing in its pediatric health platform.
- Regulatory Pathway
- How FDA and international regulatory approvals will impact the rollout of Owlet’s OnCall telehealth service.
Related topics